Sinovac's Covid-19 vaccine candidate approved for emergency use in China

China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceuti­cal (Sinopharm), also said it had obtained emergency use approval for a vaccine candidate

Sinovac Biotech Ltd's coronavirus vaccine candidate CoronaVac was approved in July for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.

China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceuti­cal (Sinopharm), also said it had obtained emergency use approval for a coronavirus vaccine candidate in social media platform WeChat on Sunday. CNBG, which has two vaccine candidates in phase 3 clinical trials, did not say which of its vaccines had been cleared for emergency use.

China has been giving experimental coronavirus vaccines